COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 699: Articles 6981-6990  | Next

Global patterns and drivers of influenza decline during the COVID-19 pandemic
Bonacina, F., Boëlle, P.-Y., Colizza, V., Lopez, O., Thomas, M., Poletto, C.
10.1101/2022.07.15.22277497 — Posted: 2022-07-17
Ethnic homophily affects vaccine prioritization strategies
Kadelka, C., Islam, M. R., McCombs, A., Alston, J., Morton, N.
10.1101/2022.07.15.22277696 — Posted: 2022-07-17
Influence of vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity
Jolliffe, D. A., Vivaldi, G., Chambers, E. S., Cai, W., Li, W., Faustini, S. E., Gibbons, J. M., Pade, C., Richter, A., McKnight, A., Martineau, A. R.
10.1101/2022.07.15.22277678 — Posted: 2022-07-17
Correlates of protection for booster doses of the BNT162b2 vaccine
Hertz, T., Levy, S., Ostrovsky, D., Oppenheimer, H., Zismanov, S., Kuzmina, A., Friedman, L., Trifkovic, S., Brice, D., Chun-Yang, L., Shemer-Avni, Y., Cohen-Lahav, M., Amichay, D., Keren-Naus, A., Voloshin, O., Weber, G., Najjar-Debbiny, R., Chazan, B., McGargill, M., Webby, R., Chowers, M., Novack, L., Novack, V., Taube, R., Nesher, L., Weinstein, O.
10.1101/2022.07.16.22277626 — Posted: 2022-07-17
Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: A protocol for a multicenter, randomized, double-blind, placebo-controlled, phase 3 study (the SCORPIO-SR trial)
Yotsuyanagi, H., Ohmagari, N., Doi, Y., Imamura, T., Sonoyama, T., Ichihashi, G., Sanaki, T., Tsuge, Y., Uehara, T., Mukae, H.
10.1101/2022.07.15.22277670 — Posted: 2022-07-17
Analysis of SARS-CoV-2 amino acid mutations in New York City Metropolitan wastewater (2020-2022) reveals multiple traits with human health implications across the genome and environment-specific distinctions
Anand, A., Long, C., Chandran, K.
10.1101/2022.07.15.22277689 — Posted: 2022-07-17
Internet-based Cognitive Behaviour Therapy for the Prevention, Treatment and Relapse Prevention of Eating Disorders: A Systematic Review
Hamid, N.
10.1101/2022.07.15.22277685 — Posted: 2022-07-17
Extended compartmental model for modeling COVID-19 epidemic in Slovenia
Fosnaric, M., Kamensek, T., Gros, J., Zibert, J.
10.1101/2022.07.16.22277702 — Posted: 2022-07-17
Assessment of COVID-19 hospitalization risk during SARS-CoV-2 Omicron relative to Delta variant predominance, New York City, August 2021-January 2022
Greene, S. K., Levin-Rector, A. K., Luoma, E., Amin, H., McGibbon, E., Mathes, R. W., Ahuja, S. D.
10.1101/2022.07.15.22276814 — Posted: 2022-07-17
From The Plague Horrors of Cholera, What Partnership Lessons Can Be Learnt in Addressing COVID-19 In Zambia
CHOTA, P., Matenga, T. F. L., Zulu, J. M., Mweemba, O.
10.1101/2022.07.15.22277666 — Posted: 2022-07-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).